Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alliacense
Verbatim Purchases CORE Flash™ Portfolio License
February 6th, 2009
Alliacense announced that Verbatim® Americas, LLC, a subsidiary of Mitsubishi Chemical Corporation, a recognized world leader in the chemical and computer industries, has purchased a license to the CORE Flash™ Patent Portfolio from The TPL Group. The agreement makes Verbatim the eighth company to purchase a CORE Flash license in the past 15 months. “We are delighted by the accelerated momentum of the CORE Flash Licensing Program,” stated Bruce Sanderson, Vice President of Licensing for Alliacense. “Following closely on the heels of our recent ASUSTeK announcement, the Verbatim agreement is another strong recognition of the value and competitive edge that CORE Flash...
Source: Health Business Week (2009-02-06)
|